Movatterモバイル変換


[0]ホーム

URL:


GB9103302D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB9103302D0
GB9103302D0GB919103302AGB9103302AGB9103302D0GB 9103302 D0GB9103302 D0GB 9103302D0GB 919103302 AGB919103302 AGB 919103302AGB 9103302 AGB9103302 AGB 9103302AGB 9103302 D0GB9103302 D0GB 9103302D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919103302A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham LtdfiledCriticalSmithKline Beecham Ltd
Priority to GB919103302ApriorityCriticalpatent/GB9103302D0/en
Publication of GB9103302D0publicationCriticalpatent/GB9103302D0/en
Priority to AU12272/92Aprioritypatent/AU1227292A/en
Priority to PCT/GB1992/000257prioritypatent/WO1992014466A1/en
Priority to ZA921093Aprioritypatent/ZA921093B/en
Priority to IE048492Aprioritypatent/IE920484A1/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

GB919103302A1991-02-161991-02-16Pharmaceutical formulationsPendingGB9103302D0 (en)

Priority Applications (5)

Application NumberPriority DateFiling DateTitle
GB919103302AGB9103302D0 (en)1991-02-161991-02-16Pharmaceutical formulations
AU12272/92AAU1227292A (en)1991-02-161992-02-13Pharmaceutical antitussive compositions
PCT/GB1992/000257WO1992014466A1 (en)1991-02-161992-02-13Pharmaceutical antitussive compositions
ZA921093AZA921093B (en)1991-02-161992-02-14Pharmaceutical formulations
IE048492AIE920484A1 (en)1991-02-161992-02-14Pharmaceutical Formulations

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB919103302AGB9103302D0 (en)1991-02-161991-02-16Pharmaceutical formulations

Publications (1)

Publication NumberPublication Date
GB9103302D0true GB9103302D0 (en)1991-04-03

Family

ID=10690127

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB919103302APendingGB9103302D0 (en)1991-02-161991-02-16Pharmaceutical formulations

Country Status (5)

CountryLink
AU (1)AU1227292A (en)
GB (1)GB9103302D0 (en)
IE (1)IE920484A1 (en)
WO (1)WO1992014466A1 (en)
ZA (1)ZA921093B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU676025B2 (en)*1993-03-291997-02-27Henry, Richard A. DrLidocaine aerosol anaesthetic
US5593661A (en)*1993-03-291997-01-14Henry; Richard A.Lidocaine aerosol anaesthetic
US5589156A (en)*1994-05-021996-12-31Henry; Richard A.Prilocaine and hydrofluourocarbon aerosol preparations
SE9601528D0 (en)*1996-04-231996-04-23Pharmacia Ab Transdermally administered dextromethorphan as an antitissue agent
JP2002517438A (en)*1998-06-092002-06-18ノートラン・ファーマシューティカルズ・インコーポレーテッド Compositions and methods for treating cough
CA2354576C (en)*1998-12-112008-10-14Pharmachemie B.V.Pharmaceutical preparation for inhalation of an opioid
IL153574A0 (en)2000-06-232003-07-06Mayo FoundationMethods of treating neutrophil-related diseases with topical anesthetics
EP1506174B1 (en)*2002-05-172015-09-30Taiwanj Pharmaceuticals Co., Ltd.Use of naltrexone for treating kidney and liver damage
EP2218448B1 (en)2002-12-132015-09-23Durect CorporationOral drug delivery system comprising high viscosity liquid carrier materials
EP2559428A1 (en)*2007-12-062013-02-20Pain Therapeutics, Inc.Micronized opioid compositions and dosage forms and methods of making same
JP2011506318A (en)2007-12-062011-03-03デュレクト コーポレーション Oral pharmaceutical formulation
US20100260844A1 (en)2008-11-032010-10-14Scicinski Jan JOral pharmaceutical dosage forms
US9555113B2 (en)2013-03-152017-01-31Durect CorporationCompositions with a rheological modifier to reduce dissolution variability
SG11201811760VA (en)2016-07-062019-01-30Durect CorpOral dosage form with drug composition, barrier layer and drug layer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CA1136547A (en)*1979-03-081982-11-30Song-Ling LinAerosol anesthetic compositions
US4241048A (en)*1979-05-011980-12-23Bristol-Myers CompanySuspension composition of benzocaine
US4454140A (en)*1982-09-071984-06-12Hoffmann-La Roche Inc.Nasal administration of dextromethorphan
IT1187743B (en)*1985-09-261987-12-23Prodotti Formenti Srl DESTRORPHANE BASED PHARMACEUTICAL COMPOSITIONS FOR INSTRANASAL APPLICATION
FR2601246B1 (en)*1986-07-111990-01-05Bouchara Sa NOVEL DEXTROMETHORPHANE-BASED ANTI-TUSSIVE COMPOSITIONS AND THEIR PROCESS FOR OBTAINING SAME.

Also Published As

Publication numberPublication date
WO1992014466A1 (en)1992-09-03
AU1227292A (en)1992-09-15
ZA921093B (en)1993-01-27
IE920484A1 (en)1992-08-26

Similar Documents

PublicationPublication DateTitle
GB9109862D0 (en)Pharmaceutical formulations
ZA921877B (en)Pharmaceutical aerosol formulations
IL102777A0 (en)Pharmaceutical combination formulation
ZA921093B (en)Pharmaceutical formulations
GB9114950D0 (en)Pharmaceutical formulation
AP9000236A0 (en)Pharmaceutical formulations
GB9201639D0 (en)Pharmaceutical formulations
GB9323399D0 (en)Pharmaceutical formulations
GB9311030D0 (en)Pharmaceutical formulations
GB9216061D0 (en)Pharmaceutical combination formulation
GB9103444D0 (en)Pharmaceutical formulations
GB9102019D0 (en)Pharmaceutical formulations
GB9111858D0 (en)Pharmaceutical formulations
GB9124803D0 (en)Pharmaceutical formulations
GB9125005D0 (en)Pharmaceutical formulations
GB9114621D0 (en)Pharmaceutical formulations
GB9014391D0 (en)Pharmaceutical formulations
GB9204774D0 (en)Pharmaceutical formulations
GB9221244D0 (en)Pharmaceutical formulations
GB9307003D0 (en)Pharmaceutical formulations
GB9203212D0 (en)Pharmaceutical formulations
GB9217602D0 (en)Pharmaceutical formulations
GB9207338D0 (en)Pharmaceutical formulations
GB9121798D0 (en)Pharmaceutical formulation
GB9116467D0 (en)Pharmaceutical formulation

[8]ページ先頭

©2009-2025 Movatter.jp